|drug786||Cognitive and behavioral intervention. Wiki||1.00|
|D000073296||Noncommunicable Diseases NIH||0.71|
|D002908||Chronic Disease NIH||0.45|
There is one clinical trial.
Under the COVID-19, individuals who were home Quarantine experienced new challenges on their parent-child relationship and couple relationship. The current project aimed to provide psychological interventions for both parents and couples in order to improving their relationship. The online intervention of group intervention and individual intervention are going to be conducted. The relationship between parent-child, couples and emotion regulation will be tested.
Description: The efficacy of parent-child conflict resolution will be assessed by the conflict subscale of the Conflict in Parent-Child Relationships. Scoring is based on a 5-point Likert scale with higher total scores indicate high level of conflict in the parent - child relationship.Measure: Parent-child conflict Time: 2 weeks
Description: The efficacy of communication, will be assessed by the family communication scale. Scoring is based on a 5-point Likert scale with regard to the quality of parent-child interactions. Higher total scores on individual and combined subscales indicate more positive parent-child interactions.Measure: Parent-child communication Time: 2 weeks
Description: The efficacy of parent-child relationship intervention will be assessed by the parent-child relationship scale. Higher total scores indicate higher quality of parent-child relationship.Measure: Parent-child Relationship Time: 2 weeks
Description: The efficacy of Couple Relationship Intervention will be assessed by the quality of marriage index. Higher total scores indicate higher quality of couple relationship.Measure: Couple Relationship Quality Time: 2 weeks
Description: The efficacy of Couple Relationship Intervention will be assessed by the stability of marriage scale-short form. Higher total scores indicate higher stability of couple relationship.Measure: Marital Stability Time: 2 weeks
Data processed on December 13, 2020.
An HTML report was created for each of the unique drugs, MeSH, and HPO terms associated with COVID-19 clinical trials. Each report contains a list of either the drug, the MeSH terms, or the HPO terms. All of the terms in a category are displayed on the left-hand side of the report to enable easy navigation, and the reports contain a list of correlated drugs, MeSH, and HPO terms. Further, all reports contain the details of the clinical trials in which the term is referenced. Every clinical trial report shows the mapped HPO and MeSH terms, which are also hyperlinked. Related HPO terms, with their associated genes, protein mutations, and SNPs are also referenced in the report.Drug Reports MeSH Reports HPO Reports